DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$1.40
+0.07 (+5.26%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+194.3% upside
Low Target
$2.96
Average Target
$4.12
High Target
$5.49
Current Price
$1.40
Current
$1.40
$1.40
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Scenario Analysis
Bear Case
$2.96
111.4%
Low target
Base Case
$4.12
+194.3%
Avg target
Bull Case
$5.49
+292.1%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$3.78
-63.0% from high
52-Week Low
$1.13
+23.9% from low
Target vs 52W High
$4.12
+9.0% vs high
Next Earnings Report
Aug 12, 2026
2d
until earnings
EPS Est: $-0.25
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals